For those surrogate outcomes , low-strength evidence failed to show difference .
In subgroup analysis , high strength evidence supported a lower BP with HBPT that lasted for 6 or 12 months and was accompanied with counselling support from study personnel .
HBPT can improve BP control in the hypertensive patients .
It may be more efficacious when a proactive additional support is provided during the intervention process
To summarise evidence about the effectiveness of home blood pressure telemonitoring ( HBPT )  and identify the key components of intervention .
A Pharmacist-Led, American Heart Association Heart360 Web-Enabled Home Blood Pressure Monitoring Program
Background —To determine whether a pharmacist-led , Heart360-enabled , home blood pressure monitoring ( HBPM ) intervention  improves blood pressure ( BP ) control compared with usual care ( UC ) . Methods and Results —This r and omized , controlled trial was conducted in 10 Kaiser Permanente Colorado clinics . Overall , 348 patients with BP above recommended levels were r and omized to the HBPM  ( n=175 ) or UC ( n=173 ) groups . There were no statistically significant differences in baseline characteristics between the groups ; however , there was a trend toward a higher baseline BP for the HBPM group compared with the UC group ( 148.8 versus 145.5 mm Hg for systolic BP ; 89.6 versus 88.0 mm Hg for diastolic BP ) . At 6 months , the proportion of patients achieving BP goal was significantly higher in the HBPM group ( 54.1 % ) than in the UC group ( 35.4 % ; P<0.001 ) . Compared with the UC group , the HBPM group experienced a −12.4-mm Hg larger ( 95 % confidence interval , −16.3 to −8.6 ) reduction in systolic BP and a −5.7-mm Hg larger ( 95 % confidence interval , −7.8 to −3.6 ) reduction in diastolic BP . The impact of the intervention on BP reduction was even larger for the subgroup of patients with diabetes mellitus or chronic kidney disease . The HBPM group had more e-mail and telephone contacts and greater medication regimen intensification . The proportion of patients reporting high satisfaction with hypertension care was significantly greater in the HBPM group ( 58 % ) than in the UC group ( 42 % ) , P<0.001 . Conclusions —A pharmacist-led , Heart360-supported , home BP monitoring intervention led to greater BP reductions , superior BP control , and higher patient satisfaction than UC . Clinical Trial Registration —URL : http://www . clinical trials.gov/ct2/show/NCT01162759 . Unique identifier : NCT01162759
For those surrogate outcomes , low-strength evidence failed to show difference .
In subgroup analysis , high strength evidence supported a lower BP with HBPT that lasted for 6 or 12 months and was accompanied with counselling support from study personnel .
HBPT can improve BP control in the hypertensive patients .
It may be more efficacious when a proactive additional support is provided during the intervention process
To summarise evidence about the effectiveness of home blood pressure telemonitoring ( HBPT )  and identify the key components of intervention .